Tonight’s Hot Topic Tuesday revisits injectable weight-loss drugs and the new discoveries coming out about the medications.

Weight-loss drugs like semaglutide and tirzepatide may help shrink waistlines, but new research shows they fail to boost ...

GLP-1 drugs like Ozempic and Mounjaro helped men with low testosterone raise their levels without hormone replacement in a ...

British Columbia's Ministry of Health is limiting the sales of two more diabetes drugs in an attempt to curb their off-label ...

Menopausal hormone replacement therapy may not directly impact your weight, but it could cause bloating and changes in body composition.

The weight loss industry is rife with pills you can pop that are marketed as boosters to help you shed pounds. Yet there is often zero scientific evidence that these remedies actually work ...

Consuming fewer calories is largely accepted as a way to improve health and lose weight, but a recently published study in Nature Metabolism points to a specific sulfur-containing amino acid ...

There is an ongoing debate on the specific effect — as well as magnitude of effect — of physical activity or exercise on weight loss and weight maintenance. This question is particularly ...

The American College of Cardiology (ACC) recommended GLP-1 drugs for first-line weight management to optimize cardiovascular health. GLP-1 medications are more effective than lifestyle ...

Insurance coverage for weight-loss drugs has recently increased, but typically only covers branded versions, according to consulting firm Mercer.

GLP-1 agonists like Wegovy, Ozempic, and Mounjaro might benefit heart and brain health—but research suggests they might also cause pregnancy complications and harm some users. Weight-loss drugs ...